Related Experiment Video
Updated: Apr 18, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
The use of ventricular assist device support in children: the state of the art
1Pediatric Cardiothoracic Surgery, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Insights
Pediatric ventricular assist devices are crucial for congenital heart disease patients. The PumpKIN Trial will compare the Berlin Heart EXCOR to the Infant Jarvik 2000, addressing critical needs in pediatric mechanical support.
Area of Science:
- Pediatric cardiology
- Mechanical circulatory support
- Congenital heart disease
Background:
- Improved survival in congenital heart disease leads to more pediatric patients with ventricular dysfunction.
- Pediatric mechanical support devices have lagged behind adult innovations.
- Existing options like extracorporeal membrane oxygenation are unsuitable for long-term pediatric support.
Purpose of the Study:
- To compare the efficacy and safety of the Berlin Heart EXCOR versus the Infant Jarvik 2000 in pediatric patients.
- To address the challenges in mechanical support for the single ventricle population.
Main Methods:
- Prospective, randomized study design (PumpKIN Trial).
- Comparison of the Berlin Heart EXCOR (paracorporeal device) with the Infant Jarvik 2000.
- Focus on a challenging pediatric population with unique anatomical and physiological considerations.
Main Results:
- Data on pediatric ventricular assist device use, particularly in single ventricle patients, are currently anecdotal.
- Mortality rates in this specific population remain high.
- A dedicated registry has been established to improve care and data collection.
Conclusions:
- The development of pediatric-specific ventricular assist devices is critical.
- The PumpKIN Trial aims to provide crucial data for optimizing mechanical support in pediatric heart failure.
- Further research and data collection through registries are essential for improving outcomes in single ventricle patients requiring mechanical support.
Abstract:
Improved survival, recognition, and management of patients with congenital heart disease have increased the number of pediatric patients with ventricular dysfunction. Many of these patients require mechanical support to bridge to transplant or recovery. Development of pediatric ventricular assist devices has lagged behind adult devices. Until recently, adult devices were used in pediatric patients, with suboptimal results in the smaller patient population. Extracorporeal membrane oxygenation can be life saving, but is a poor choice for long-term support. The Berlin Heart EXCOR (Berlin Heart AG, Berlin, Germany) is a paracorporeal device with a variety of pumps for patients of all sizes. The PumpKIN Trial will compare this device to the Infant Jarvik 2000 (Jarvik Heart, New York, NY, USA) in a prospective, randomized study. The single ventricle population presents unique challenges to placement and proper functioning of assist devices. Data are anecdotal and mortality is high. A registry has been developed to assist in caring for this challenging population.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...

